Amber Therapeutics
Founded 2021 · 63 employees on LinkedIn · 5 known investors
Amber Therapeutics develops medical technology focused on treating mixed urinary incontinence, advancing toward pivotal clinical trials in the US with expanded feasibility studies in Europe.
Investors · 5
Funding
SEC filings, press & company announcements$100M disclosed across 1 of 2 rounds · 2024–2026
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 3
by search overlap
Amber9 shared keywordsAmber Bio is a biotechnology company developing a novel RNA writing platform capable of multi-kilobase gene edits that can treat multiple mutations across patients with a single product.
Bioworld5 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
LatticeWork5 shared keywordsAmber makes private cloud storage devices paired with a mobile and desktop app, letting consumers back up photos and files from Android, iOS, macOS, and Windows without a subscription. The devices offer remote access, media streaming, and on-device AI for facial and object recognition to organize images and remove duplicates.
Companies competing with Amber Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Amber Therapeutics do?
- Amber Therapeutics develops medical technology focused on treating mixed urinary incontinence, advancing toward pivotal clinical trials in the US with expanded feasibility studies in Europe.
- Who are Amber Therapeutics's investors?
- Amber Therapeutics's investors include F-Prime Capital, Intuitive Ventures, Lightstone Ventures, New Enterprise Associates (NEA), Oxford Science Enterprises.
- How much funding has Amber Therapeutics raised?
- Amber Therapeutics has disclosed $100M raised across 1 of its 2 known rounds.